Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...

A cellular-resolution map of prenatal brain development in Down syndrome reveals disrupted neuron production timing and altered cell types.

Frequent drug price revisions in Japan are pushing companies to improve cost efficiency, reinforcing the case for outsourcing ...

One Biosciences notes that the local Albany life sciences ecosystem gives us access to a community of like-minded researchers ...

The results of a study by researchers at the International Centre for Genetic Engineering and Biotechnology (ICGEB) suggest that the heart’s constant beating may actively suppress tumor growth in ...

AI in cancer research has moved decisively past theory. The focus is now on how to gain researchers' and clinicians' trust.

At AACR, first‑in‑human KIR‑CAR T data show early activity in solid tumors and introduce a novel design aimed at limiting T ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.

Investigational ADC QLS5132 showed promising clinical benefit and manageable safety in Phase I trial patients with platinum-resistant ovarian cancer.

These “on‑demand” probes, known as VIS‑Fbs, become brightly fluorescent only when they bind their intended protein targets.

Eli Lilly has agreed to acquire Kelonia Therapeutics for up to $7 billion, in a deal that would bolster the buyer’s oncology ...